(0.24%) 5 103.50 points
(0.59%) 38 608 points
(0.53%) 17 744 points
(0.20%) $79.11
(-0.74%) $2.02
(0.19%) $2 314.10
(0.34%) $26.92
(0.41%) $966.50
(-0.07%) $0.932
(-0.09%) $10.98
(-0.13%) $0.797
(0.62%) $91.69
2.15% $ 0.405
@ $0.636
Emitido: 13 feb 2024 @ 14:17
Retorno: -36.35%
Señal anterior: feb 9 - 14:07
Señal anterior:
Retorno: -7.76 %
Live Chart Being Loaded With Signals
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States...
Stats | |
---|---|
Volumen de hoy | 128 479 |
Volumen promedio | 2.73M |
Capitalización de mercado | 5.76M |
EPS | $0 ( 2024-03-29 ) |
Próxima fecha de ganancias | ( $-0.190 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.510 |
ATR14 | $0.00400 (0.98%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-15 | Zeldis Jerome B | Buy | 38 136 | Stock Option (Right to Buy) |
2023-12-15 | Parks Diane L. | Buy | 38 136 | Stock Option (Right to Buy) |
2023-12-15 | Rubin Robert J. | Buy | 38 136 | Stock Option (Right to Buy) |
2023-12-15 | Lapointe Anthony Gregg | Buy | 38 136 | Stock Option (Right to Buy) |
2023-12-08 | Donini Oreola | Buy | 90 000 | Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 96 transactions |
Buy: 3 883 139 | Sell: 81 030 |
Volumen Correlación
Soligenix Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
ANDE | 0.913 |
ALBO | 0.892 |
CMPI | 0.89 |
PALT | 0.879 |
VAXX | 0.867 |
MLAC | 0.863 |
NATI | 0.859 |
OTRK | 0.857 |
PLRX | 0.857 |
OCSL | 0.852 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Soligenix Inc Correlación - Moneda/Commodity
Soligenix Inc Finanzas
Annual | 2023 |
Ingresos: | $839 359 |
Beneficio Bruto: | $90 757.00 (10.81 %) |
EPS: | $-0.790 |
FY | 2023 |
Ingresos: | $839 359 |
Beneficio Bruto: | $90 757.00 (10.81 %) |
EPS: | $-0.790 |
FY | 2022 |
Ingresos: | $948 911 |
Beneficio Bruto: | $398 089 (41.95 %) |
EPS: | $-4.81 |
FY | 2021 |
Ingresos: | $33 351.00 |
Beneficio Bruto: | $-695 289 (-2 084.76 %) |
EPS: | $-0.310 |
Financial Reports:
No articles found.
Soligenix Inc
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of treat cutaneous T-cell lymphoma; and SGX942, an innate defense regulator technology that is in Phase III clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer. This segment also offers proprietary formulations of oral beclomethasone 17,21-dipropionate for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation, including SGX203 for pediatric Crohn's disease; and SGX302 that is in Phase I/II clinical trial for the treatment of mild-to-moderate psoriasis. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase Ia and Ib clinical trials; SGX943, a therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; and CiVax, a vaccine candidate in pre-clinical development for the prevention of COVID-19. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico